A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD)Laymen Terminology Chronic Bronchitis and Emphysema

Interventions

DRUG

Placebo

Oral dose bid

DRUG

AZD5069 50mg

Oral dose bid

DRUG

AZD5069 80mg

Oral dose bid

Trial Locations (8)

Research Site, Sofia

Research Site, Berlin

Research Site, Großhansdorf

Research Site, Debrecen

Research Site, Pécs

Research Site, Százhalombatta

Research Site, Szeged

Research Site, Kyiv